/term/is-policy-acquisition-expense/SHSE:688137 Suzhou Novoprotein Scientific Co (SHSE:688137) Policy Acqui
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Suzhou Novoprotein Scientific Co Ltd (SHSE:688137) » Definitions » Policy Acquisition Expense

Suzhou Novoprotein Scientific Co (SHSE:688137) Policy Acquisition Expense


View and export this data going back to 2022. Start your Free Trial

What is Suzhou Novoprotein Scientific Co Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.

Suzhou Novoprotein Scientific Co (SHSE:688137) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Suzhou Novoprotein Scientific Co Ltd (SHSE:688137) » Definitions » Policy Acquisition Expense
Comparable Companies
SZSE:000710 SHSE:688068 SZSE:300583 BJSE:430047 SZSE:301166 SZSE:300238 SZSE:300147 SZSE:002868 SZSE:300381 SHSE:688670 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
No. 228, Yunchuang Road, 3rd & 4th Floor, Wujiang Economic and Technological Development Zone, Jiangsu Province, Suzhou, CHN, 215299
Website
http://www.novoprotein.com.cn
Suzhou Novoprotein Scientific Co Ltd is a high-tech enterprise focusing on recombinant protein application solutions. Its main business is the research and development of target and cytokine proteins, recombinant antibodies, enzymes and reagents, Production and sales, and provide related technical services.